You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

OHT

Showing 1 - 25 of 163
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Open Angle Glaucoma (POAG), Primary Open Angle Glaucoma of Both Eyes, Primary Open-Angle Glaucoma, Unspecified Eye Trial

Not yet recruiting
  • Primary Open Angle Glaucoma (POAG)
  • +3 more
  • Experimental: QLS-111 ophthalmic solution, (0.015%)
  • +4 more
  • (no location specified)
Aug 30, 2023

Vivity in Patients With Well Controlled Glaucoma

Recruiting
  • Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
  • Vivity Extended Depth of Focus
  • Montréal, Quebec, Canada
    Clinique Bellevue
Sep 29, 2021

Open Angle Glaucoma, Ocular Hypertension Trial in United States (OTX-TIC low dose Travoprost Intracameral Implant, OTX-TIC high

Recruiting
  • Open Angle Glaucoma
  • Ocular Hypertension
  • OTX-TIC low dose Travoprost Intracameral Implant
  • +2 more
  • Delray Beach, Florida
  • +8 more
Apr 12, 2022

Impact of Self-tonometry on Glaucoma Treatment Decision.

Completed
  • Glaucoma
  • +3 more
  • Unchanged treatment
  • Changed treatment
  • Stockholm, Sweden
    St Erik Eye Hospital
Mar 1, 2022

Atypical Hyperplasia, Lobular Carcinoma in Situ Trial in Rochester (Tamoxifen, Topical 4-OHT( 4-hydroxytamoxifen)gel 2 mg/each

Recruiting
  • Atypical Hyperplasia
  • Lobular Carcinoma in Situ
  • Evanston, Illinois
  • +1 more
Jan 20, 2023

Glaucoma, OHT - Ocular Hypertension Trial in Rochester, Omaha, Columbus (Timolol 0.5% ophthalmic solution, Latanoprost 0.005%

Recruiting
  • Glaucoma
  • OHT - Ocular Hypertension
  • Timolol 0.5% ophthalmic solution
  • Latanoprost 0.005% Ophthalmic Solution
  • Rochester, Minnesota
  • +2 more
Jul 15, 2022

Caries, Dental, Health Behavior Trial in Boston (OHT Parent targeted text messages, CWT Parent targeted text messages)

Completed
  • Caries, Dental
  • Health Behavior
  • OHT Parent targeted text messages
  • CWT Parent targeted text messages
  • Boston, Massachusetts
    Boston Medical Center
May 19, 2022

Mammographically Dense Breast Trial in United States (Afimoxifene, Laboratory Biomarker Analysis, Placebo)

Active, not recruiting
  • Mammographically Dense Breast
  • Tampa, Florida
  • +4 more
Dec 27, 2022

OAG - Open-Angle Glaucoma, OHT - Ocular Hypertension Trial (Netarsudil 0.02% QD, Timolol maleate 0.5% BID)

Withdrawn
  • OAG - Open-Angle Glaucoma
  • OHT - Ocular Hypertension
  • Netarsudil 0.02% QD
  • Timolol maleate 0.5% BID
  • (no location specified)
Mar 17, 2022

Mammographic Breast Density Trial in Germany, Spain, United States (4-OH tamoxifen, Placebo)

Terminated
Has Results
  • Mammographic Breast Density
  • 4-OH tamoxifen
  • Placebo
  • Mesa, Arizona
  • +18 more
Oct 20, 2021

Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost SR, LUMIGAN)

Completed
  • Open-Angle Glaucoma
  • Ocular Hypertension
  • Dothan, Alabama
  • +5 more
May 17, 2022

Open Angle Glaucoma, Ocular Hypertension Trial in United States (Travoprost, Placebo Vehicle)

Completed
Has Results
  • Open Angle Glaucoma
  • Ocular Hypertension
  • Artesia, California
  • +9 more
Sep 14, 2021

Metastatic Breast Adenocarcinoma, Breast Cancer Trial in Switzerland (CR1447)

Active, not recruiting
  • Metastatic Breast Adenocarcinoma
  • Breast Cancer
  • Aarau, Switzerland
  • +12 more
Feb 3, 2022

OAG - Open-Angle Glaucoma, OHT - Ocular Hypertension Trial in La Jolla (Latanoprostene bunod 0.024% QD, Timolol maleate 0.5%

Completed
  • OAG - Open-Angle Glaucoma
  • OHT - Ocular Hypertension
  • Latanoprostene bunod 0.024% QD
  • Timolol maleate 0.5% BID
  • La Jolla, California
    UCSD Shiley Eye Institute
Jul 2, 2021

Primary Open Angle Glaucoma, Ocular Hypertension Trial in Setagaya-Ku (Netarsudil ophthalmic solution 0.02%, Ripasudil HCl

Completed
  • Primary Open Angle Glaucoma
  • Ocular Hypertension
  • Netarsudil ophthalmic solution 0.02%
  • Ripasudil hydrochloride hydrate ophthalmic solution 0.4%
  • Setagaya-Ku, Tokyo, Japan
    Seijo Clinic
Aug 29, 2021

Cancer Survivor, Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma Trial in Chicago (drug, procedure, other)

Recruiting
  • Cancer Survivor
  • +2 more
  • Chicago, Illinois
    Northwestern University
Dec 2, 2020

Atelectasis on RVEDP Following Orthotropic Heart Transplantation

Not yet recruiting
  • Heart Transplant Failure
  • Anesthesia
  • Lung Recruitment
  • (no location specified)
Nov 27, 2023

Open Angle Glaucoma, Ocular Hypertension Trial in Te Aro, Rotorua (100ng/day PA5346 Latanoprost FA SR Ocular Implant)

Recruiting
  • Open Angle Glaucoma
  • Ocular Hypertension
  • 100ng/day PA5346 Latanoprost FA SR Ocular Implant
  • Te Aro, Wellington, New Zealand
  • +1 more
Apr 10, 2022

POAG Trial (Eagle)

Not yet recruiting
  • POAG
  • Eagle
  • (no location specified)
Jun 5, 2023

HIV Trial (HIV self-testing with online supervision)

Not yet recruiting
  • HIV
  • HIV self-testing with online supervision
  • (no location specified)
Mar 22, 2023

Ocular Hypertension, Primary Open Angle Glaucoma Trial in United States (Latanoprost ophthalmic solution, AKB-9778, Placebo)

Completed
  • Ocular Hypertension
  • Primary Open Angle Glaucoma
  • Latanoprost ophthalmic solution
  • +2 more
  • Inglewood, California
  • +20 more
Jan 13, 2021

Breast Cancer Trial in Esch-sur-Alzette, Luxembourg (Medication adherence eHealth intervention)

Recruiting
  • Breast Cancer
  • Medication adherence eHealth intervention
  • Esch-sur-Alzette, Luxembourg
  • +1 more
Apr 11, 2022

Ductal Breast Carcinoma In Situ, Estrogen Receptor Positive Trial in United States (Afimoxifene, Laboratory Biomarker Analysis,

Recruiting
  • Ductal Breast Carcinoma In Situ
  • Estrogen Receptor Positive
  • Chicago, Illinois
  • +5 more
Dec 17, 2020

Preservative-free Fixed-dose Combination of Tafluprost 0.0015% /

Completed
  • Ocular Surface Disease
  • Primary Open Angle Glaucoma
  • Tafluprost, timolol maleate
  • Taoyuan city, Taiwan
    Chang-Geng Medical Foundation Linkou Chang-Geng Memorial Hospita
Oct 27, 2022

Ocular Hypertension Trial in Australia (FM101 tablet, FM101 oral solution, Placebo)

Recruiting
  • Ocular Hypertension
  • FM101 tablet
  • +4 more
  • Bella Vista, New South Wales, Australia
  • +4 more
Jul 18, 2022